Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Aikido Pharma Inc. on December 8, 2021. The filing details the outcomes of three proposals submitted to security holders, including the election of directors, ratification of the independent auditor, and an advisory vote on executive compensation.
Key Financial Metrics
This filing is a current report regarding corporate governance events and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes and Voting Results
The filing discloses the final voting results for the Annual Meeting. Approximately 50% of total outstanding shares were represented, constituting a quorum.
- Proposal 1 (Election of Directors): Robert J. Vander Zanden and Tim S. Ledwick were elected as Class I directors for a term expiring at the 2024 annual meeting.
- Proposal 2 (Ratification of Auditor): The appointment of WithumSmith + Brown PC as the independent registered public accounting firm for the fiscal year ending December 31, 2021, was ratified.
- Proposal 3 (Executive Compensation): The Company's executive compensation was approved via a non-binding advisory vote.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, risks, contingencies, or unusual items. The document is strictly limited to reporting the submission of matters to a vote of security holders.
Key Facts for Investor Verification
- Verify the tenure of newly elected directors Robert J. Vander Zanden and Tim S. Ledwick (Class I, expiring 2024).
- Confirm the appointment of WithumSmith + Brown PC as the auditor for the fiscal year ending December 31, 2021.
- Note the significant number of votes withheld or cast against proposals, particularly the advisory vote on executive compensation (10,548,644 votes against vs. 12,382,812 votes for).
- Review the company's most recent 10-K or 10-Q for financial performance data, as this 8-K contains no financial metrics.